Clinical study results show that methylation of the SLC6A4 promoter is associated with increased susceptibility to depression (Olsson et al., 2010), and higher SLC6A4 promoter methylation is significantly associated with childhood adversity (Kang et al., 2013). The gene discussed is SLC6A4; the disease is depressive symptom measurement.